Art

J-GLOBAL ID：201802290780871628   Reference number：18A1071091

Feasibility of tissue re-biopsy in non-small cell lung cancers resistant to previous epidermal growth factor receptor tyrosine kinase inhibitor therapies

以前の表皮成長因子受容体チロシンキナーゼ阻害剤療法に耐性の非小細胞肺癌における組織再生検の実現可能性【JST・京大機械翻訳】

Author (14)： Uozu Sakurako (Department of Respiratory Medicine, Fujita Health University School of Medicine, Toyoake, Japan) ,  Uozu Sakurako (Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Imaizumi Kazuyoshi (Department of Respiratory Medicine, Fujita Health University School of Medicine, Toyoake, Japan) ,  Yamaguchi Teppei (Department of Respiratory Medicine, Fujita Health University School of Medicine, Toyoake, Japan) ,  Goto Yasuhiro (Department of Respiratory Medicine, Fujita Health University School of Medicine, Toyoake, Japan) ,  Kawada Kenji (Department of Clinical Oncology, Fujita Health University Hospital, Toyoake, Japan) ,  Minezawa Tomoyuki (Department of Respiratory Medicine, Fujita Health University School of Medicine, Toyoake, Japan) ,  Okamura Takuya (Department of Respiratory Medicine, Fujita Health University School of Medicine, Toyoake, Japan) ,  Akao Ken (Department of Respiratory Medicine, Fujita Health University School of Medicine, Toyoake, Japan) ,  Hayashi Masamichi (Department of Respiratory Medicine, Fujita Health University School of Medicine, Toyoake, Japan) ,  Isogai Sumito (Department of Respiratory Medicine, Fujita Health University School of Medicine, Toyoake, Japan) ,  Okazawa Mitsushi (Department of Respiratory Medicine, Daiyukai General Hospital, Ichinomiya, Japan) ,  Hashimoto Naozumi (Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Hasegawa Yoshinori (Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan)
Material： BMC Pulmonary Medicine (Web)
Volume： 17  Issue： 1  Page： 175  Publication year： 2017 
JST Material Number： U7449A  ISSN： 1471-2466  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： When epidermal growth factor r...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1071091&from=J-GLOBAL&jstjournalNo=U7449A") }}

Thesaurus term： *biopsy ,  therapeutic planning ,  patient ,  standardization ,  sensitivity ,  remission ,  recurrence ,  genetic variation ,  *EGF receptor ,  molecular target therapy ,  pleural effusion ,  *non-small cell lung cancer
Semi thesaurus term： RECIST ,  *再生検 ,  *チロシンキナーゼ阻害剤 , 【Automatic Indexing@JST】

Author keywords (7)： Re-biopsy ,  Molecular targeted therapy ,  EGFR-TKI ,  Metastasis ,  Retrospective analysis ,  Bronchoscopy ,  CT guided needle biopsy

JST classification (3)： Tumors(=neoplasms)of respiratory system  (GI04000G) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Reference (32)：

• CA Cancer J Clin; Cancer treatment and survivorship statistics; KD Miller, RL Siegel, CC Lin, AB Mariotto, JL Kramer, JH Rowland; 66; 2016; 271-289; 10.3322/caac.21349; citation_id=CR1
• N Engl J Med; Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma; TS Mok, YL Wu, S Thongprasert, CH Yang, DT Chu, N Saijo; 361; 2009; 947-957; 10.1056/NEJMoa0810699; citation_id=CR2
• N Engl J Med; Gefitinib or chemotherapy for non-small- cell lung cancer with mutated EGFR; M Maemond, A Inoue, K Kobayashi, S Sugawara, S Oizumi, H Isobe; 362; 2010; 2380-2388; 10.1056/NEJMoa0909530; citation_id=CR3
• Ther Adv Resp Dis; Management of advanced non-small cell lung cancers with known mutations or rearraengements: latest evidence and treatment approaches; M Shea, DB Costa, D Rangachari; 10; 2016; 113-129; 10.1177/1753465815617871; citation_id=CR4
• Cancer Sci; Not all EGFR mutations in lung cancer are created equal: perspectives for individualized treatment strategy; Y Kobayashi, T Mitsudomi; 107; 2016; 1179-1186; 10.1111/cas.12996; citation_id=CR5

Terms in the title (8)： 表皮成長因子受容体 ,  チロシンキナーゼ阻害剤 ,  療法 ,  耐性 ,  非小細胞肺癌 ,  組織 ,  再生検 ,  実現可能性